Prevalence of Anemia in Patients with Chronic Kidney Disease

• Mustafa Rahouma

  1Higher Institute of Science and Medical Technology, Medical Laboratories Department, Tripoli/Abusalim

  Author

• Omaro A. Aburas

  Higher Institute of Science and Medical Technology, Pharmacy Department, Tripoli/Abusalim

  Author

• Abtisam Miftah Dhaw

  Higher Institute of Science and Medical Technology, Pharmacy Department, Tripoli/Abusalim.

  Author

• Aisha Maidon

  Higher Institute of Science and Medical Technology, Pharmacy Department, Tripoli/Abusalim

  Author

• Emhamed Boras

  Libyan Academy of postgraduate Studies, Life Science Department, Tripoli/ Janzor.

  Author

Anaemia is a frequent side effect in individuals with chronic kidney disease (CKD). It is primarily caused by a decrease in the proportion of erythropoietin (EPO), which can happen when there is a decrease in the quantity of haemoglobin in the blood or in the number of red blood cells. The purpose of this study is to look into the severity and prevalence of anaemia in adult patients who are not on dialysis. Materials and Procedures: The kidney department laboratory data at Tripoli Hospital and the records of individuals aged 30 to 70 years old comprised the research sample. In this study, 80 persons in total were categorised into different stages of CKD based on the KDIGO guidelines. Individuals suffering from severe haemorrhage, acute renal failure, and those Ages under eighteen were not included. The study's findings revealed that the patients' ages varied from 22 to 85 years old, with an average age of 49 ± 13 years. Of these, forty were between 40 and 59 years old (50.0%), seventeen were 60 years of age or older (21.3%), and twenty-three were between the ages of 20 and 39 (28.7%). Because of this study, a little higher proportion of women than males. Of the 80 patients, 34 patients (42.5%) were male and 46 patients (57.5%) were female. Additionally, this resulted in the fourth quarter's prevalence of early-stage anaemia being in stage one (10.0), with 2.5% of patients in stage 0 and no patients in stage 4, and the bulk of patients in stage 0. Five (62.5%). 18% of the patients, or fifteen, were in stage two. At 6.2%, these rates were in the third stage. Finds that there are 65 patients (81.2%) with anaemia and 15 patients (18.8%) with normal haemoglobin levels. These numbers indicate the prevalence of anaemia. And I discovered that it related to a character of that kind, and I also discovered that some of those individuals are donors. About 76.5% of females had anaemia (haemoglobin levels below 12 g/dl), and approximately 23.5% had normal (haemoglobin levels exceeding 12 g/dl). Additionally, Figure 5 demonstrates that the percentage of men with anaemia (haemoglobin levels below 13 g/dl) was around 84.8%, whereas the percentage of men with normal haemoglobin levels above 13 g/dl was roughly 15.2%. Approximately 75% of the anaemic Nineteen anaemic patients were in stage two (15.4%), four anaemic patients were in stage three (6.2%), three anaemic patients were in the first stage (4.6%), and patients were in stage five (73.8%). In conclusion, the study's findings show that anaemia prevalence rises as kidney function deteriorates, demonstrating a direct correlation between anaemia frequency and declining kidney function.

• pdf

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.